Diabetes Treatments Market

1
Diabetes Treatments Market Trends, Size, Share,
Demands, Overview, Growth, Revenue and Forecast
to 2030
sales_at_delvens.com www.delvens.com
2
Sternal Closure Systems Market Trends Forecast
Till 2030
Diabetes Treatments Market, By Drug Class
(Insulin, DPP-4 Inhibitors, GLP-1 Receptor
Agonists, SGLT2 Inhibitors), By Diabetes Type
(Type-1, Type-2), By Distribution Channel (Online
pharmacies, Hospital Pharmacies, Retail
Pharmacies), and region (North America, Europe,
Asia-Pacific, Middle East and Africa and South
America).
Request For Free Sample Report
https//www.delvens.com/get-free-sample/diabetes-t
reatments-market
sales_at_delvens.com
www.delvens.com
3
Market Overview
The global diabetes treatment market is a dynamic
sector driven by the prevalence of diabetes
mellitus, a metabolic disorder characterized by
elevated blood sugar levels due to insufficient
insulin production or improper cell response to
insulin. This chronic condition affects millions
worldwide and necessitates a comprehensive market
for managing and treating its symptoms
effectively. Key drivers of market growth
include the escalating incidence of obesity, a
significant risk factor for type 2 diabetes. As
obesity rates rise globally, so does the
prevalence of diabetes, fueling demand for
advanced treatment options. Technological
advancements play a pivotal role, with continuous
glucose monitoring systems and innovative insulin
delivery devices revolutionizing diabetes
management. These technologies offer precise and
individualized solutions, marking a shift towards
personalized medicine in diabetes
care. Purchase this Report https//www.delvens
.com/checkout/diabetes-treatments-market
sales_at_delvens.com
www.delvens.com
4
Key Findings
The Diabetes Treatments Market is segmented into
Drug Class, Diabetes Type, Distribution Channel,
and Region. On the basis of Drug Class, the
insulin segment is poised for substantial growth
in the global diabetes treatment market, driven
by increasing demand from both Type-1 and some
Type-2 diabetes patients, surpassing 30 million
people as of 2020. On the basis of Diabetes
Type, Type 2 diabetes affects the majority of
individuals with diabetes, characterized by the
body's reduced ability to effectively use
insulin, known as insulin resistance. As Type 2
diabetes progresses, insulin production by the
pancreas may decline. Concurrently, Type 1
diabetes cases are also increasing, contributing
to market revenue. Recent reports indicate
approximately 1.6 million Americans, including
150,000 youth, have Type 1 diabetes, with around
61,000 new cases annually.
sales_at_delvens.com
www.delvens.com
5
Key Findings
The market is also divided into various regions
such as North America, Europe, Asia-Pacific,
South America, and Middle East and Africa. North
America is estimated to account for the largest
market share during the forecast period. Inquire
Before Buying https//www.delvens.com/Inquire-bef
ore-buying/diabetes-treatments-market
sales_at_delvens.com
www.delvens.com
6
Competitive Landscape

• Home Diagnostics Inc.
• Novartis AG
• Eli Lilly and Company.
• Merck Co., Inc
• AstraZeneca
• Boehringer Ingelheim International GmbH
• Takeda Pharmaceutical Company Limited

• Roche Products Limited
• Johnson Johnson Services, Inc.
• Sanofi-Deutschland GmbH
• Novo Nordisk A/S
• ARKRAY USA, Inc.
• Bayer AG
• Amylin Pharmaceuticals Inc.
• Abbott
• Medtronic Inc.
• Teva Pharmaceuticals Pvt Ltd.

sales_at_delvens.com
www.delvens.com
7
Recent Developments
In October 2022, Novo Nordisk intends to seek
regulatory approval for once-weekly insulin
icodec, positioning it as a potential leading
treatment for type 2 diabetes. The pharmaceutical
firm plans to submit applications in the US, EU,
and China by mid-2023 following positive results
from the ONWARDS 5 phase 3a trial comparing it to
once-daily basal insulin over 52 weeks. In May
2022, Novo Nordisk plans to invest around USD 98
million to modernize and expand its insulin
production facility located in Kalundborg,
Denmark.
sales_at_delvens.com
www.delvens.com
8
Contact Information
About Us Delvens is a strategic advisory and
consulting company headquartered in New Delhi,
India. The company holds expertise in providing
syndicated research reports, customized research
reports and consulting services. Delvens
qualitative and quantitative data is highly
utilized by each level from niche to major
markets, serving more than 1K prominent companies
by assuring to provide the information on
country, regional and global business
environment. We have a database for more than 45
industries in more than 115 major countries
globally. Contact Us 44-20-3290-6466 1
214-377-1144 sales_at_delvens.com
sales_at_delvens.com
www.delvens.com